BioSpace News Archive

Lone Star Bio

Polsinelli Releases White Paper on Key Factors Driving Rapid Transformation of National Health Care Ecosystem Toward a More Patient-Centric Model

“Health Care ‘Prime’” analysis seeks to explain the future state of health care being shaped through mergers and acquisitions and innovation as the drivers predominantly utilized by those accelerating the remaking of health care in America

October 9, 2018
·
4 min read
Le-Vel Announces Multiple Product Launches, Fall Promotional Lineup

Billion-dollar company to end most successful year in its history on powerful note

October 9, 2018
·
3 min read
Drug Development

IAVI Announces Clinical Trial of Next-Generation HIV Vaccine Candidate Designed to Induce Antibodies to Block HIV Infection

Phase I Trial to Evaluate Safety and Immunogenicity of Vaccine Candidate Engineered to Elicit Targeted Immune Response Against HIV

October 9, 2018
·
8 min read
Drug Development

Medical Breakthrough on a Global Scale and Significant Achievement for Kadimastem

For the first time ever, the company has transplanted cells derived from embryonic stem cells in ALS patients

October 9, 2018
·
7 min read
Business

StemCyte and Fulgent Genetics Partner to Provide Comprehensive Genetic Analysis for Families

StemCyte and Fulgent Genetics are proud to announce a new partnership to offer comprehensive genetic testing to support the health of growing families. Two genetic tests, “Beacon Expanded Carrier Screening” and “Newborn Genetic Analysis (NGA),” will now be offered through StemCyte and powered by Fulgent Genetics.

October 9, 2018
·
3 min read
Business

Medical Marijuana, Inc. Announces Q3 2018 as the Largest Sales Bookings Quarter in Company History

Medical Marijuana, Inc. today announced that the company and its subsidiary Kannaway® have booked their largest-ever sales revenue quarter in their history in Q3 2018, as well as reached major milestones in their business operations.

October 9, 2018
·
5 min read
Biotech Beach

Agendia Announces Level 1 Inclusion of MammaPrint® Breast Cancer Test in Updated National Comprehensive Cancer Network® (NCCN) Guidelines

The NCCN recommends Agendia’s MammaPrint® breast cancer test with the highest level of evidence for early-stage breast cancer patients with estrogen receptor-positive, lymph-node negative and lymph-node positive (LN+ 1-3)

October 9, 2018
·
5 min read
At the Forefront of Ovarian Cancer Treatment - Sheba Medical Center Offers TIL Trials

Sheba is proud to be the only hospital worldwide to offer this revolutionary therapy for ovarian cancer, still in active research.

October 9, 2018
·
2 min read
Pharm Country

Mucinex Survey Reveals Millions Of Americans Hide Being Sick

Enter Mucinex Cold & Flu All in One, Multi-Symptom Relief in One Convenient Formula

October 9, 2018
·
5 min read
Genetown

Agenus To Present Data on Proprietary CTLA-4 & PD-1 Antibodies at ESMO 2018

AGEN PD-1 antibody (AGEN2034) shows early signs of clinical activity in patients with cervical cancer

October 9, 2018
·
4 min read